|
Article Cited by others ORIGINAL ARTICLE
Relationship between toxicities and clinical benefits of newly approved tyrosine kinase inhibitors in thyroid cancer: A meta-analysis of literature
Ye Xiaobing, Zhu Yiping, Cai Juan
Year : 2015| Volume: 11| Issue : 6 | Page no: 185-190 | This article has been cited by | | 1 |
Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors |
|
| | Amit Kumar Choudhary, George Abraham, Vijay Maruti Patil, Nandini Menon, Tanmoy Mandal, Sobin Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy, Dipti Nakti, Neha Mittal, Munita Bal, Swapnil Rane, Nilendu Purandare, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Vanita Noronha, Kumar Prabhash | | | Indian Journal of Surgical Oncology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Usefulness of CyberKnife Therapy in Patients with Differentiated Thyroid Cancer with Distant Metastases
|
|
| | Atsushi Yoshida, Shigeaki Higashiyama, Yutaka Katayama, Takashi Yamanaga, Joji Kawabe | | | An International Journal of Otorhinolaryngology Clinics. 2021; 12(2): 38 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Bronchial artery aneurysms arising from antiangiogenic therapy |
|
| | Miguel Borregón Rivilla, Katherin Aly Martínez Barroso, Elia Martínez Moreno, Alba María Ramos Garrido, Irene Ramos Reguera, Manuel Alejandro Mazariegos Rubí, Beatríz Berzal Hernández, Aitana Palomares Morales, Celia Ástor Rodríguez, Ruth Álvarez Cabellos | | | Current Problems in Cancer. 2020; 44(6): 100569 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation |
|
| | Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte, Aditya Shenoy | | | Health Technology Assessment. 2020; 24(2): 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer |
|
| | Kenji Makita, Yasushi Hamamoto, Shintaro Tsuruoka, Noriko Takata, Yusuke Urashima, Masao Miyagawa, Teruhito Mochizuki | | | International Journal of Clinical Oncology. 2020; 25(4): 691 | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
Two thyroid cancer patients who received lenvatinib |
|
| | Mioko Matsuo | | | JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 2016; 26(2): 259 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
